Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate Cancer

Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate Cancer

<p>  </p> <div><strong>Article full text</strong></div> <p> The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few...

Full description

Saved in:
Bibliographic Details
Main Author: AdisRapid Journals on behalf of: (12118901) (author)
Other Authors: Alberto Russu (5677178) (author), Anasuya Hazra (4722045) (author), Hui Tian (322212) (author), Nahor Haddish-Berhane (20508634) (author), Juan Jose Perez Ruixo (14997866) (author), Muriel Boulton (20508635) (author)
Published: 2025
Subjects:
Medicine
Nephrology and Urology
Oncology and Carcinogenesis not elsewhere classified
niraparib
abiraterone
population pharmacokinetics
fixed-dose combination
dual-action tablets
prostate cancer
Digital Features
Graphical Abstract
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items